In the current study a combination of serotonin reuptake inhibition with FKBP51 blockade might be beneficial for the treatment of symptoms that relate to stress coping, while positive AD effects on anxiety-related parameters can be hampered by the disruption of FKBP51 functionality. This evidence concerns the gene FKBP5 and Anxiety.